Cinemark Holdings Inc (CNK):企業の財務・戦略的SWOT分析

◆英語タイトル:Cinemark Holdings Inc (CNK) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15267
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Cinemark Holdings Inc (CNK) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cinemark Holdings, Inc. (Cinemark) is a motion picture exhibitor. The company operates theatres across the US, Brazil, Argentina, Bolivia, Curacao, Chile, Colombia, Paraguay, Peru, Honduras, Ecuador, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala. It develops new platforms and market adaptive concepts for its theatre circuit in the US, which include XD, Cinemark Reserve, Luxury Lounger recliner seats, motion seats, enhanced food and beverage and other premium concepts. It also offers in-theatre dining with food options that includes fresh wraps, burgers, hot sandwiches and gourmet pizzas, as well as wines, beers and frozen cocktails. The company uses digital projection technology in its domestic theatres and first-run international theatres. Cinemark is headquartered in Plano, Texas, the US.

Cinemark Holdings Inc Key Recent Developments

Oct 29,2018: Cinemark signs long-term renewable energy deal with AEP Energy Partners
Aug 08,2018: Cinemark Holdings posts results for three and six months ended June 30, 2018
Feb 23,2018: Cinemark Holdings posts results for three and twelve months ended December 31, 2017
Feb 06,2018: Cinemark promotes Jay Jostrand as senior vice president of real estate
Jan 25,2018: Cinemark Promotes Sean Gamble to Chief Operating Officer and Appoints Wanda Gierhart to Chief Marketing Officer January 25, 2018

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Cinemark Holdings Inc – Key Facts
Cinemark Holdings Inc – Key Employees
Cinemark Holdings Inc – Key Employee Biographies
Cinemark Holdings Inc – Major Products and Services
Cinemark Holdings Inc – History
Cinemark Holdings Inc – Company Statement
Cinemark Holdings Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Cinemark Holdings Inc – Business Description
Business Segment: International Markets
Overview
Performance
Target Markets
Business Segment: US Markets
Overview
Performance
Cinemark Holdings Inc – Corporate Strategy
Cinemark Holdings Inc – SWOT Analysis
SWOT Analysis – Overview
Cinemark Holdings Inc – Strengths
Cinemark Holdings Inc – Weaknesses
Cinemark Holdings Inc – Opportunities
Cinemark Holdings Inc – Threats
Cinemark Holdings Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Recent Developments
Oct 29, 2018: Cinemark signs long-term renewable energy deal with AEP Energy Partners
Aug 08, 2018: Cinemark Holdings posts results for three and six months ended June 30, 2018
Feb 23, 2018: Cinemark Holdings posts results for three and twelve months ended December 31, 2017
Feb 06, 2018: Cinemark promotes Jay Jostrand as senior vice president of real estate
Jan 25, 2018: Cinemark names Sean Gamble as chief operating officer and hires Wanda Gierhart as chief marketing officer
Jan 25, 2018: Cinemark Promotes Sean Gamble to Chief Operating Officer and Appoints Wanda Gierhart to Chief Marketing Officer January 25, 2018
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Cinemark Holdings Inc, Key Facts
Cinemark Holdings Inc, Key Employees
Cinemark Holdings Inc, Key Employee Biographies
Cinemark Holdings Inc, Major Products and Services
Cinemark Holdings Inc, History
Cinemark Holdings Inc, Subsidiaries
Cinemark Holdings Inc, Key Competitors
Cinemark Holdings Inc, Ratios based on current share price
Cinemark Holdings Inc, Annual Ratios
Cinemark Holdings Inc, Annual Ratios (Cont...1)
Cinemark Holdings Inc, Annual Ratios (Cont...2)
Cinemark Holdings Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Cinemark Holdings Inc, Performance Chart (2014 - 2018)
Cinemark Holdings Inc, Ratio Charts

★海外企業調査レポート[Cinemark Holdings Inc (CNK):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Air New Zealand Limited:企業の戦略・SWOT・財務情報
    Air New Zealand Limited - Strategy, SWOT and Corporate Finance Report Summary Air New Zealand Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Amgen Inc (AMGN)-医療機器分野:企業M&A・提携分析
    Summary Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to improve the lives of patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncol …
  • VLP Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary VLP Therapeutics LLC (VLP) is a biopharmaceutical company that develops therapeutic vaccines and next generation of targeted antibody agents to address global unmet medical needs. The company offers product such as vaccines for the treatment of cancer types such as breast, lung, prostate can …
  • Nielsen Holdings PLC:企業の戦略・SWOT・財務分析
    Nielsen Holdings PLC - Strategy, SWOT and Corporate Finance Report Summary Nielsen Holdings PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Adamas Pharmaceuticals Inc (ADMS):製薬・医療:M&Aディール及び事業提携情報
    Summary Adamas Pharmaceuticals Inc (Adamas Pharmaceuticals) is a pharmaceutical company that develops and commercializes therapeutics for chronic disorders of the central nervous system. The company's Gocovri, formerly ADS-5102, is an amantadine extended-release (XR) formulation for the treatment fo …
  • Continental Grain Company
    Continental Grain Company - Strategy, SWOT and Corporate Finance Report Summary Continental Grain Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Paychex, Inc.:企業の戦略・SWOT・財務情報
    Paychex, Inc. - Strategy, SWOT and Corporate Finance Report Summary Paychex, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • University of Birmingham-医療機器分野:企業M&A・提携分析
    Summary University of Birmingham is an academic research university that offers educational services. The university provides undergraduate, postgraduate, postgraduate research, and distance learning programs. It offers educational courses in various fields including accounting, astronomy, computer …
  • GeNeuro SA (GNRO):企業の財務・戦略的SWOT分析
    Summary GeNeuro SA (GeNeuro) is a clinical stage pharmaceutical company that manufactures therapeutic product pipeline for disorders of the nervous system. The company provides treatments against inflammatory and degenerative disorders associated with endogenous retroviruses. GeNeuro develops therap …
  • EaglePicher Technologies LLC:企業の戦略的SWOT分析
    EaglePicher Technologies LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Servier Canada Inc-製薬・医療分野:企業M&A・提携分析
    Summary Servier Canada Inc (SCI), a subsidiary of Les Laboratoires Servier SAS is a manufacturer and distributor of generic and ethical products. The company’s products include perindopril erbumine tablets, perindopril erbumine indaparride tablets, glidazide modified release tablets, glidazide table …
  • Seacor Holdings Inc (CKH):石油・ガス:M&Aディール及び事業提携情報
    Summary Seacor Holdings Inc (Seacor) is a diversified holding company that offers domestic and international transportation and logistics and risk management consultancy services. The company operates through business segments such as ocean transportation and logistics services, inland transportatio …
  • Frequency Electronics Inc:企業の戦略・SWOT・財務分析
    Frequency Electronics Inc - Strategy, SWOT and Corporate Finance Report Summary Frequency Electronics Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • RCL Foods Ltd (RCL):企業の財務・戦略的SWOT分析
    RCL Foods Ltd (RCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Development Bank of Southern Africa:企業の戦略的SWOT分析
    Development Bank of Southern Africa - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Peyto Exploration & Development Corp (PEY):石油・ガス:M&Aディール及び事業提携情報
    Summary Peyto Exploration & Development Corp (Peyto Exploration & Development) is an oil and gas exploration and development company that acquires, explores, develops and produces crude oil and unconventional natural gas reserves. The company operates the Alberta Deep Basin, a geologic setting locat …
  • Peloton Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Peloton Therapeutics Inc (Peloton) is a clinical-stage pharmaceutical company that develops oral medicines and novel therapies for oncology. Its portfolio of pipeline products includes PT2977, PT2567 and PT2385. The company develops its products for the treatment of pulmonary arterial hypert …
  • Evgen Pharma Plc (EVG)-製薬・医療分野:企業M&A・提携分析
    Summary Evgen Pharma Plc (Evgen Pharma), formerly Evgen Pharma Ltd is a drug discovery company that develops medicines to treat cancer and neurological diseases. The company uses sulforadex technology that synthesizes and concurrently stabilizes the naturally occurring compound such as sulforaphane. …
  • AMETEK Inc (AME):企業の財務・戦略的SWOT分析
    Summary AMETEK Inc (AMETEK) is an electronic products manufacturer. The company manufactures electronic instruments and electromechanical devices. Its product portfolio includes medical materials, motion control systems, sub assemblies and connectors, electrical cord reels, gauges, titanium alloys a …
  • Proteomics International Laboratories Ltd (PIQ):医療機器:M&Aディール及び事業提携情報
    Summary Proteomics International Laboratories Ltd (Proteomics International) is a medical technology company that discovers new biopharmaceutical drugs. The company harnesses its proprietary proteomics-based technology platform to work in three integrated areas; diagnostics, analytical services and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆